Introduction
Ionotropic glutamate receptors (iGluRs) come in four flavors: AMPA, NMDA, kainate, and d (GluD). The GluD subtypes, GluD1 (GluRd1) and GluD2 (GluRd2), were identified more than 20 years ago [1] [2] [3] [4] . Despite considerable sequence similarities to the other iGluRs in their putative ligand-binding domains (LBDs; see Glossary), GluD1 and GluD2 have been referred to as 'orphan receptors' until recently because their endogenous ligands were unknown. GluD2 is predominantly expressed in cerebellar Purkinje cells and plays crucial roles in motor coordination and motor learning [1] [2] [3] [4] . By contrast, GluD1 is predominantly expressed in the inner ear and plays an essential role in high-frequency hearing [5] . Furthermore, various mutations in the genes encoding GluD1 and GluD2 in mice (Grid1, Grid2) and human (GRID1, GRID2) cause cognitive dysfunction. Nevertheless, the mechanisms underlying the GluD1 and GluD2 functions in neural circuits have long remained elusive.
In recent years, however, this situation has changed significantly, mostly due to the identification of two extracellular endogenous ligands for GluD2 in the cerebellum: D-serine and Cbln1. While D-serine binds to the LBD [6], Cbln1 binds to the amino-terminal domain (ATD) of GluD2 [7, 8] . Although endogenous ligands for GluD1 are still unknown, D-serine and Cbln family proteins (i.e., Cbln1, Cbln2, and Cbln4) bind to GluD1, at least in vitro [7, 9] . GluD2 does not show any direct channel activity upon binding of known ligands (Box 1). Instead, GluD2 activation induces endocytosis of AMPA-type iGluRs during long-term depression (LTD), a form of synaptic plasticity involved in cerebellar motor learning. This metabotropic signaling mode, independent of channel activity, has recently captured the spotlight because it appears to be widespread among iGluRs, complementing their canonical ionotropic functions (Box 2). Endogenous ligands that bind to the ATD of other iGluRs have also been identified. Thus, the function of iGluRs may generally be regulated by cooperative binding of ligands, one at the ATD and another at the LBD (Box 3), and a mechanistic understanding of GluD1/D2 will likely provide broader insights into iGluR signaling at neuronal synapses. As it is often the case in science, answering one question triggers many others. However, this is a good time to summarize what has been learned about GluD receptors, celebrate their belated coming-of-age, and overview future research directions.
Trends
GluD1 and GluD2 were thought to be expressed preferentially in the inner ear and the cerebellum.
Recent work has demonstrated that both GluD receptors are expressed in multiple brain regions, including the cerebral cortex and hippocampus.
Human genetic studies also indicate their involvement in various neurodevelopmental and psychiatric disorders.
Two extracellular endogenous ligands for GluD2 were identified in the cerebellum. Cbln1, released from and tethered to the presynaptic sites via neurexin, binds to the GluD2 aminoterminal domain (ATD). D-Serine, released from Bergmann glia, binds to the GluD2 ligand-binding domain (LBD).
The transsynaptic triad of neurexinCbln1-GluD2 serves as a potent bidirectional synaptic organizer.
Simultaneous binding of D-serine to the LBD and Cbln1 to the ATD cooperate to induce GluD2 signaling leading to AMPA receptor endocytosis. This process is mediated by the cytoplasmic protein tyrosine phosphatase PTPMEG, which interacts with the C-terminal domain of GluD2.
